Streetbeat News

Earnings

ETR

Entergy (NYSE:ETR) reported Q1 adjusted earnings per share of $1.08, missing the consensus estimate of $1.51 by 28.48%. This represents a 5.26% decrease from the $1.14 per share reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:40 am

CPF

Central Pacific Financial (CPF) reported Q1 2024 earnings of $0.48 per share, surpassing the $0.45 estimate, but missed sales estimates by a slight margin with $50.187M against the expected $50.230M. This represents a 7.40% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:40 am

BSX

Boston Scientific has projected its Q2 2024 adjusted earnings per share (EPS) to be in the range of $0.57-$0.59, surpassing the consensus estimate of $0.56.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:40 am

ENPH

NOVA

RUN

SEDG

Solar stocks are trading lower following Enphase's disappointing Q1 financial results and lower than expected Q2 revenue guidance. This has negatively impacted the sector, including companies like NOVA, RUN, and SEDG.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:40 am

PB

Prosperity Bancshares (NYSE:PB) reported Q1 2024 earnings of $1.18 per share, surpassing the $1.16 estimate, with sales of $277.114M also beating the $277.072M estimate, despite a 1.64% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:39 am

BSX

Boston Scientific projects its Q2 2024 net sales to grow by about 10.5%-12.5% year-over-year on a reported basis, and around 10%-12% on an organic basis.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:39 am

WAB

Wabtec shares surged following the announcement of stronger than anticipated Q1 financial outcomes and an upward revision of its 2024 guidance.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:38 am

HUM

Humana's stock price increased following the announcement of their Q1 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:38 am

BSX

Boston Scientific has updated its 2024 adjusted EPS guidance to $2.29-$2.34, an increase from the previous guidance of $2.23-$2.27, and above the consensus estimate of $2.25.

Portfolio Pulse from Benzinga Newsdesk

April 24, 2024 | 10:38 am

QQQ

SPY

TSLA

TXN

Nasdaq and S&P 500 futures rose due to positive guidance from Tesla and Texas Instruments, with investors eyeing upcoming economic data. The SPDR S&P 500 ETF Trust and Invesco QQQ ETF saw premarket gains. Analysts suggest the market rally could resume with the right catalyst, amid expectations of favorable inflation data. Tesla, Texas Instruments, and other companies showed significant premarket movements following their earnings reports.

Portfolio Pulse from Shanthi Rexaline

April 24, 2024 | 10:37 am